Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could treadmill workouts be the key to soothing diabetic shoulder pain?

NCT ID NCT07784543

Symptom relief Sponsor: Pamukkale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study tests whether adding moderate-intensity aerobic exercise (like treadmill walking) to standard shoulder rehabilitation can reduce shoulder pain and disability in people with type 2 diabetes who also have a common shoulder tendon problem called supraspinatus tendinopathy. Half of the participants will receive only conventional physical therapy, while the other half will also do aerobic exercise five days a week for six weeks. Researchers will measure changes in pain, disability, and tendon structure using ultrasound to see if the added exercise brings extra benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Aerobic exercise (moderate-intensity treadmill) added to conventional shoulder rehabilitation
What this could lead to
If effective, this could lead to a more comprehensive rehabilitation approach for people with diabetes and shoulder pain, potentially improving pain and function without extra medication.
What could go wrong
This is a small early-stage trial with only 24 participants, so results may not apply broadly. The added benefit of aerobic exercise over standard rehab alone is uncertain, and some people may find treadmill exercise difficult.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 30-70 years. * Having a diagnosis of type 2 diabetes mellitus (T2DM) for more than 1 year. * Having unilateral or bilateral shoulder pain for at least 3 months and a diagnosis of supraspinatus tendinopathy confirmed by magnetic resonance imaging (MRI). * Having a pain intensity score of ≥3 on the Visual Analog Scale (VAS). * No participation in regular exercise during the past 6 months Exclusion Criteria: * Having received shoulder rehabilitation within the past 6 months. * Having a full-thickness tear of the supraspinatus tendon. * Having a history of fracture, surgery, or injection in the upper extremity within the past 6 months. * Having a diagnosis of a neuromuscular disease, rheumatic disease, or severe cardiovascular disease. * Having advanced diabetic complications. * Having any condition that contraindicates or prevents participation in aerobic exercise.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Supraspinatus tendinopathy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease of the tendon Shoulder Pain type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Supraspinatus tendinopathy Type 2 diabetes mellitus (T2DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Pamukkale University, Denizli

    Denizli, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.